4D Molecular Therapeutics Inc - FDMT - stock price prediction, stock price target, analyst ratings from 11 analysts

4D Molecular Therapeutics Inc has a share price target of US$ 33, revenue growth forecast of 94250.0%, and profit growth estimate of -28.3% for FY25, based on top 11 analyst calls.